Side-by-side comparison of AI visibility scores, market position, and capabilities
Athletic apparel company with $5.5B revenue executing premium repositioning under Kevin Plank; HeatGear/ColdGear performance fabrics and Curry basketball shoes competing with Nike and Adidas.
Under Armour is an American sportswear and athletic apparel company producing performance clothing, footwear, and accessories designed for athletic training and competitive sports — competing with Nike and Adidas for athletic apparel market share through its technical fabric innovations (HeatGear, ColdGear, MotionFit) and sports performance marketing. Founded in 1996 by Kevin Plank in Baltimore, Maryland and listed on NYSE (NYSE: UAA/UA), Under Armour generates approximately $5.5 billion in annual revenue with significant North American concentration and ongoing challenges expanding internationally and beyond its male athletic core.\n\nUnder Armour's product categories include apparel (athletic compression and training gear, team uniforms, outerwear), footwear (HOVR running shoes, Curry basketball shoes through its Steph Curry partnership), and accessories. The brand built its early success on compression shirts that athletes preferred for moisture management, then expanded into all athletic categories. The HOVR running franchise and Curry 12 basketball shoe represent the brand's most important footwear lines.\n\nIn 2025, Under Armour is executing a multi-year restructuring under CEO Kevin Plank (who returned to lead the company in 2023 after several years away) that prioritizes brand repositioning toward premium athletic performance and away from the discount and fashion channels that diluted brand equity in the 2017-2022 period. The company has reduced its SKU count, pulled back from promotional discounting, and refocused on performance credibility. Under Armour competes with Nike, Adidas, and Lululemon for athletic apparel market share. The 2025 strategy focuses on the US premium repositioning, growing international markets (particularly Asia), and deepening its connected fitness platform (MapMyFitness, MyFitnessPal).
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.